Industry news

FDA 'Taking a Very Light Touch' on Regulating the Apple Watch

Adam Satariano / Bloomberg Business

With Apple Inc. and fellow Silicon Valley companies edging further into health care, the U.S. agency in charge of oversight says it will give the technology industry leeway to develop new products without aggressive regulation.

CAP, AMP Among Groups Jointly Issuing Colorectal Cancer Molecular Testing Draft Recommendations

GenomeWeb

NEW YORK (GenomeWeb) – Several oncology and pathology groups have jointly issued draft recommendations for labs regarding analysis of colorectal cancer patients' samples for certain prognostic and predictive molecular markers.

Fleming Europe Ensuring Quality of Russian Pharma Manufacturing

Pharmaceutical-Tech.com

Russian pharmaceutical market is developing rapidly, it takes 11th place in the rating of pharmaceutical markets' volume in the world and is predicted to go up to the 9th place by 2016. Along with growing potential, important changes in the industry take place due to governmental program “Pharma 2020”.

Finance giants lobby for JOBS-style reforms to EU IPO laws

Nick Paul Taylor / Fierce Biotech

A consortium of financial trade groups has begun lobbying the European Commission to implement the sort of changes that triggered the U.S. biotech IPO boom. The European IPO Task Force specifically wants politicians to slash the regulatory and administrative cost of going public by up to 50%, a move that would make it financially feasible for more small companies to float.

Federal Trade Commission cracking down on questionable mobile medical apps

Varun Saxena / FierceMedicalDevices

Although the FDA is taking a hands-off attitude toward regulating new forms of health information technology, the Federal Trade Commission has stepped up enforcement of those app makers that make false or misleading claims. 

100,000 Genomes Project taps Big Pharma dream team for data crunching skills

Nick Paul Taylor / Fierce BiotechIT

The United Kingdom has wasted no time getting industry involved with its 100,000 Genomes Project. With just 3% of the sequencing work done, Genomics England has enlisted the help of a who's who of Big Pharma companies to pore over the data in search of new avenues for drug discovery.

27 March 2015

Neothetics Reports Fourth Quarter and Full Year 2014 Financial Results

Neothetics, Inc.(Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today reported financial results for the fourth quarter and year ended December 31, 2014.

Early clinical trial rate slowing in Asia despite obvious advantages

Cornelia Zou / BioWorld

Despite a number of advantages as a site for early stage clinical trials, Asia not only lags other regions in the world but the proportion of studies it hosts is actually dropping.

Great support can, must be brought to broader swath of biomedical enterprise

Anette Breindl / BioWorld

Two weeks ago, the NIH and FDA had their say to the Senate Health, Education, Labor and Pensions (HELP) Committee on how to enable those agencies to most effectively speed the development of new drugs and devices. 

Lomonosov MSU ranks 25th in 2015 World Reputation Rankings

MarchMont Innovation News

The Lomonosov Moscow State University (MSU)  ranks 25th  in this year’s World Reputation Rankings list of the world’s best universities, next to a Singaporean university (24th) and a Chinese one (26th ). This is the highest position Russia’s most renowned university has had so far in a ranking like this, the Russian news agency RIA Novosti  reported .